Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bayley

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancerHester Lieng, Melania Pintilie, Andrew Bayley, et al.
Radiation Oncology (London, England)|November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improveJarad M Martin, Andrew Bayley, Robert Bristow, et al.
The Laryngoscope|January 2, 2025
Delayed Postoperative Radiotherapy in Head & Neck Cancers-A Systematic Review and Meta-AnalysisNoémie Villemure-Poliquin, Rui Fu, Karolina Gaebe, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Results of radiotherapy for primary subglottic squamous cell carcinomaSonya Paisley, Padraig R Warde, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Truths and myths about radiotherapy for verrucous carcinoma of larynxShao Hui Huang, Gina Lockwood, Jonathan Irish, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Cone-beam CT assessment of interfraction and intrafraction setup error of two head-and-neck cancer thermoplastic masksMichael Velec, John N Waldron, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 26, 2012
Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancerWarren D Foltz, Andy Wu, Peter Chung, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancerHester Lieng, Melania Pintilie, Andrew Bayley, et al.
Radiation Oncology (London, England)|November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improveJarad M Martin, Andrew Bayley, Robert Bristow, et al.
The Laryngoscope|January 2, 2025
Delayed Postoperative Radiotherapy in Head & Neck Cancers-A Systematic Review and Meta-AnalysisNoémie Villemure-Poliquin, Rui Fu, Karolina Gaebe, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Results of radiotherapy for primary subglottic squamous cell carcinomaSonya Paisley, Padraig R Warde, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Truths and myths about radiotherapy for verrucous carcinoma of larynxShao Hui Huang, Gina Lockwood, Jonathan Irish, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Cone-beam CT assessment of interfraction and intrafraction setup error of two head-and-neck cancer thermoplastic masksMichael Velec, John N Waldron, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 26, 2012
Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancerWarren D Foltz, Andy Wu, Peter Chung, et al.
Pageof 12